ctDNA

18 registered clinical trials studyying ctDNA — 13 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Usi NCT07478705	Sunnybrook Health Sciences Centre	N/A
Withdrawn	Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD NCT07475923	M.D. Anderson Cancer Center	—
Not Yet Recruiting	Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinom NCT07507916	Fudan University	Phase 2
Recruiting	ctDNA-guided Treatment Decision-making NCT07394218	Fudan University	Phase 2
Enrolling By Invitation	Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Lo NCT07371247	The First Affiliated Hospital with Nanjing Medical University	EARLY_Phase 1
Not Yet Recruiting	A Study of Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer NCT07254156	Sun Yat-sen University	—
Recruiting	A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cance NCT07136077	M.D. Anderson Cancer Center	Phase 2
Recruiting	SMC Radiation Oncology SABR Cohort for Oligometastasis NCT07121335	Samsung Medical Center	—
Not Yet Recruiting	Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions NCT06649838	Peking Union Medical College Hospital	—
Recruiting	A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy NCT06792786	The Central Hospital of Lishui City	N/A
Not Yet Recruiting	Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy NCT06707974	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	—
Recruiting	French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) NCT06287749	University Hospital, Montpellier	—
Not Yet Recruiting	French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM) NCT06287723	University Hospital, Montpellier	—
Active Not Recruiting	Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description NCT05029869	University Medical Center Ho Chi Minh City (UMC)	—
Unknown	Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-ra NCT04741633	Fudan University	—
Recruiting	A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening NCT07176962	Yingbin Liu, MD, PhD, FACS	—
Active Not Recruiting	ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial NCT04084249	Claus Lindbjerg Andersen	N/A
Unknown	The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal Cancer NCT03416478	Sixth Affiliated Hospital, Sun Yat-sen University	—